Despite prophylactic measures, more than half of severely immunocompromised patients acquire infections. The burden of management thus weighs heavily on diagnosis and treatment, both of which have serious limitations. No matter what prophylactic or therapeutic measures have been initiated for a given type of infection, close clinical monitoring for infectious complications is always essential.